SureTrader Advertisement PRTC
Home > Boards > Canadian > Biotechs >

Trillium Therapeutics Inc. (TRIL)

TRIL RSS Feed
Add TRIL Price Alert      Hide Sticky   Hide Intro
Moderator: NY1972
Search This Board:
Last Post: 5/24/2016 11:01:15 PM - Followers: 33 - Board type: Free - Posts Today: 0

    
                                  

Stem Cell Therapeutics (SCTPF or SSS.V)

 

Stem Cell Therapeutics

http://www.stemcellthera.com/

 

Stem Cell Therapeutics Corp.

Suite 1000, 1520 - 4th Street SW

Calgary, Alberta, Canada T2R1H5

Phone: 403.245.5495

Fax: 403.245.5411

 

About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a public biotechnology company (TSX VENTURE:SSS) focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is a leader in the development of therapies that utilize drugs to stimulate a patient's own resident stem cells. The Company's programs aim to repair brain and nerve function lost due to disease or injury. The Company's extensive patent portfolio of owned and licensed intellectual property supports the potential expansion into future clinical programs in numerous neurological diseases such as traumatic brain injury, multiple sclerosis, Huntington's disease, Alzheimer's disease, and ALS.

 

REASONS TO INVEST IN STEM CELL THERAPEUTICS

http://www.stemcellthera.com/IR.aspx

 

 

Press Releases:

 

 

DEC 11, 2009 - Stem Cell Therapeutics Corp. Adds Another U.S. Patent to Its Intellectual Property Portfolio

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1089614&year=2009&releaseSeq=0

 

Dec 10, 2009 - Stem Cell Therapeutics Corp. Announces Additional U.S. Patent

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1088967&year=2009&releaseSeq=0

 

Nov 25, 2009 - Stem Cell Therapeutics Corp. Announces Regenerative Medicine Panel Discussion led by Dr. Allen Davidoff

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1081994&year=2009&releaseSeq=0

 

Nov 23, 2009 - Stem Cell Therapeutics Corp. Announces Third Quarter Financial Results

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1080555&year=2009&releaseSeq=0

 

Nov 20, 2009 - Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb Stroke Trial

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1079955&year=2009&releaseSeq=0

 

Nov 12, 2009 - Stem Cell Therapeutics Corp. Announces That Dr. Allen Davidoff Will Present at the 2009 Neural Restoration Workshop Series

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1075491&year=2009&releaseSeq=0

 

Oct 29, 2009 - Stem Cell Therapeutics Corp. Closes Financing for $2,186,941

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1068127&year=2009&releaseSeq=0

 

Oct 08, 2009 - Stem Cell Therapeutics Corp. Announces Private Placement

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1056964&year=2009&releaseSeq=0

 

Oct 02, 2009 - Stem Cell Therapeutics Corp.: Dr. Alan Moore Will Present the Company's Brain and Neural Regeneration Therapy for the Treatment of Stroke and Multiple Sclerosis at the 2009 Banff Venture Forum

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1053981&year=2009&releaseSeq=0

 

Sep 23, 2009 - Stem Cell Therapeutics Corp. Announces That Dr. Alan Moore Will Present a Novel, Drug-Based Approach to Neuron Regeneration at the 2009 World Stem Cell Summit

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1048957&year=2009&releaseSeq=1

 

 

-----------------------------------------------------------
 

 

 

Sedar   http://www.sedar.com/homepage_en.htm

 

TMX.  http://www.tmx.com/

 

TMXmoney   http://www.tmxmoney.com/en/index.html

 

CNW Group Newswire   http://www.cnxmarketlink.com/en/index.cgi

 

Canadian Insider

http://canadianinsider.com/coReport/allTransactions.php?ticker=sss

 
Currency Converter:
http://www.bankofcanada.ca/en/rates/converter.html

 

FOR FURTHER INFORMATION PLEASE CONTACT:

Stem Cell Therapeutics Corp.
Alan Moore, PhD
President and CEO
(403) 245-5495 ext.224
amoore@stemcellthera.com


or


Stem Cell Therapeutics Corp.
Chloe Douglas-Crampton
Investor Relations
(403) 245-5495 ext. 221
crampton@stemcellthera.com
www.stemcellthera.com

 

 -----------------------------------------------------------
 

Financial Reports:
http://www.stemcellthera.com/IR.aspx?section=reports

 

CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter:  http://www.bankofcanada.ca/en/rates/converter.html



Using chart for Canadian ticker until Stockcharts adds SCTPF to their database.

 

 

 [chart]stockcharts.com/c-sc/sc?s=SSS.V&p=D&b=5&g=0&i=p21248829804&a=189138722&r=1945[/chart]



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Last update 4.13.2010

 

Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TRIL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
TRIL News: Report of Foreign Issuer (6-k) 05/18/2016 05:01:38 PM
TRIL News: Report of Foreign Issuer (6-k) 05/13/2016 07:12:23 AM
TRIL News: Report of Foreign Issuer (6-k) 04/21/2016 07:02:25 AM
TRIL News: Report of Foreign Issuer (6-k) 04/14/2016 07:23:13 AM
TRIL News: Report of Foreign Issuer (6-k) 04/12/2016 07:04:44 AM
PostSubject
#218   Weissman: We showed that anti-CD47 blocking antibodies synergize NY1972 05/24/16 11:01:15 PM
#217   Sievers, Eric L Indirect bought more in the public NY1972 05/23/16 11:03:41 AM
#216   PD-L1 antibody in urothelial bladder cancer NY1972 05/22/16 11:51:51 PM
#215   CD47 would be more promising if Hu5F9-G4 P1 NY1972 05/22/16 04:49:07 PM
#214   Great post why big pharma has to view super_trades 05/22/16 11:54:32 AM
#213   IT: live attenuated oral (SABIN) serotype 1 poliovirus vaccine NY1972 05/21/16 09:58:31 PM
#212   Tumoral IFN? mRNA and PD-L1 protein expression to NY1972 05/21/16 09:31:38 PM
#211   PD-L1 was detected with the highest frequency in NY1972 05/21/16 09:08:14 PM
#210   PLX3397 was well tolerated and readily crossed the NY1972 05/21/16 04:19:09 PM
#209   Here is some human data on PLX3397 http://www.ncbi.nlm.nih.gov/pubmed/26449250 jondoeuk 05/21/16 08:38:57 AM
#208   Hu5F9-G4 P1 data analysis by Dewophile: NY1972 05/20/16 10:27:25 PM
#207   CSF-1R inhibition reprograms macrophages to become antitumorigenic by NY1972 05/20/16 10:19:56 PM
#206   I have a few rules. One of which jondoeuk 05/20/16 12:22:05 PM
#205   For some reason a little bit of power jondoeuk 05/20/16 12:17:42 PM
#204   anyone here think this company could mess around bfsingle 05/19/16 12:40:12 PM
#203   No calreticulin effect? 75 mil from billionaires for NY1972 05/18/16 08:04:39 PM
#202   IDO/gemcitabine / nab-paclitaxel for the treatment of metastatic NY1972 05/18/16 06:18:38 PM
#201   ASCO URL NY1972 05/18/16 06:05:52 PM
#200   Hu5F9-G4 P1 data NY1972 05/18/16 05:47:01 PM
#199   Let see what 75 mil bought. Let ONCS NY1972 05/17/16 09:02:06 PM
#198   Explaining what the trial is.... Ha Ha Ha. jondoeuk 05/16/16 05:17:34 PM
#197   Phase I GS-5829 (a BET inhibitor) in adults NY1972 05/16/16 11:16:30 AM
#196   It's frustrating but soon enough it will erupt. ronpopeil 05/09/16 08:30:29 PM
#195   When will this stock get some recognition? $80M smallcapguru 05/09/16 07:56:09 PM
#194   Q: What will TRIL present at ASCO-2016? NY1972 05/04/16 04:12:53 PM
#193   We'll soon see jondoeuk 04/22/16 11:46:58 AM
#192   Well, I guess I lost our little side RockRat 04/20/16 03:38:10 PM
#191   Hoping results are strong. I would think they ronpopeil 04/20/16 09:28:53 AM
#190   Stanford is presenting human cd47 data at ASCO super_trades 04/20/16 09:18:31 AM
#189   Immuno-Oncology Combinations NY1972 04/18/16 09:11:41 PM
#188   This implied MTD was found earlier than expected NY1972 04/17/16 12:25:56 PM
#187   That's odd??. The info from the clinicaltrials.gov site jondoeuk 04/17/16 12:14:40 AM
#186   Pac-Man at Stanford, why P1 stopped at 20?? NY1972 04/16/16 11:22:58 PM
#185   anti-CSF-1R (c-fms) antibody NY1972 04/16/16 10:43:10 PM
#184   Ox40 Eleven of 70 pts (16%) have been NY1972 04/16/16 10:40:41 PM
#183   Bought some nice cash and science low floater akamaii 04/14/16 01:22:30 PM
#182   Fusion between cancer cells and macrophages NY1972 04/14/16 11:59:11 AM
#181   CD163/CD68 ratio (an indicator of M2 polarisation) was NY1972 04/07/16 03:05:43 PM
#180   Close-up of pancreatic cancer cells, why the smaller NY1972 04/07/16 02:10:09 PM
#179   I am out. WarrenE 04/06/16 02:54:23 PM
#178   13G filings NY1972 04/06/16 11:38:20 AM
#177   combinations will dominate treatment strategies, probably starting with NY1972 04/05/16 12:20:30 PM
#176   microglia acts like TAM NY1972 04/05/16 11:02:55 AM
#175   Hopefully it goes up another 20% .. WarrenE 04/04/16 01:38:14 PM
#174   TAM and breast cancer NY1972 04/04/16 01:22:34 PM
#173   MCSF-polarized M2 macrophages as well as CSC-conditioned NY1972 04/04/16 12:25:04 PM
#172   TAMs facilitate almost every step of the metastatic NY1972 04/03/16 05:30:27 PM
#171   combination of immunotherapy and radiation therapy NY1972 04/03/16 11:45:27 AM
#170   PC and immune therapies NY1972 04/03/16 11:21:28 AM
#169   Cabozantinib is a potent targeted therapy that inhibits MET NY1972 04/03/16 11:00:00 AM
PostSubject